H. BÖLEK Et Al. , "Evaluating the prognostic role of glucose-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors in first line: a study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC)," Clinical and Translational Oncology , vol.27, no.7, pp.3110-3120, 2025
BÖLEK, H. Et Al. 2025. Evaluating the prognostic role of glucose-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors in first line: a study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC). Clinical and Translational Oncology , vol.27, no.7 , 3110-3120.
BÖLEK, H., Kuzu, O. F., Sertesen Camoz, E., Sim, S., Sekmek, S., Karakas, H., ... Isık, S.(2025). Evaluating the prognostic role of glucose-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors in first line: a study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC). Clinical and Translational Oncology , vol.27, no.7, 3110-3120.
BÖLEK, HATİCE Et Al. "Evaluating the prognostic role of glucose-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors in first line: a study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC)," Clinical and Translational Oncology , vol.27, no.7, 3110-3120, 2025
BÖLEK, HATİCE Et Al. "Evaluating the prognostic role of glucose-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors in first line: a study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC)." Clinical and Translational Oncology , vol.27, no.7, pp.3110-3120, 2025
BÖLEK, H. Et Al. (2025) . "Evaluating the prognostic role of glucose-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors in first line: a study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC)." Clinical and Translational Oncology , vol.27, no.7, pp.3110-3120.
@article{article, author={HATİCE BÖLEK Et Al. }, title={Evaluating the prognostic role of glucose-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors in first line: a study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC)}, journal={Clinical and Translational Oncology}, year=2025, pages={3110-3120} }